In well-controlled tumors, the majority of TILs are effector CD8 T cells activated either in tumor-draining lymphnodes by antigen cross-presenting dentritic cells (DCs), or in the tumor by cross-reactive APC cells [176]. This evidence concerns the gene CD8A and neoplasm.